Skip to main content
. 2022 Mar 16;115(6):1490–1500. doi: 10.1093/ajcn/nqac055

FIGURE 3.

FIGURE 3

Cumulative incidence rates of total cardiovascular events1 and CVD death, according to year of follow-up, in the cocoa extract group and placebo group. 1Primary outcome (left panel): a composite of myocardial infarction, stroke, CVD death, CABG/PCI, unstable angina including hospitalization, carotid artery surgery, and peripheral artery surgery. Secondary outcome (right panel): CVD death. Summary statistics were from Cox regression models that stratified baseline hazard functions by multivitamin trial randomization group, age, sex, and recruitment cohort (intention-to-treat analyses). P value was for the effect of randomization group, based on a stratified score (log-rank) test. Rates (%) were annualized. CABG/PCI, coronary artery bypass graft and percutaneous coronary intervention; CVD, cardiovascular disease.